These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4614438)

  • 1. The use of frusemide and propranool in the treatment of the hypertension of chronic renal disease.
    Wilkinson R; Pickering M; Robson V; Elliott RW; Kerr DN
    Scott Med J; 1974; 19 Suppl 1():25-32. PubMed ID: 4614438
    [No Abstract]   [Full Text] [Related]  

  • 2. The relative roles of sodium and renin in the hypertension of renal disease. An assessment based on the response to frusemide and propranolol.
    Wilkinson R; Sellars L; Pickering M; Robson V; Kerr DN
    Clin Nephrol; 1981 Dec; 16(6):307-13. PubMed ID: 7032775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency.
    Lowenstein I; Alterman L; Zelen R; Bank DE; Bank N
    J Clin Pharmacol; 1984 Oct; 24(10):436-45. PubMed ID: 6392352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between plasma renin activity and blood pressure response to antihypertensive agents. A proposal for management of essential and renal hypertension.
    Tanaka K; Fukiyama K; Kumamoto K; Yamamoto Y; Oniki H; Omae T
    Jpn Circ J; 1975 Jul; 39(7):805-10. PubMed ID: 1159940
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of sodium nitroprussiate and diazoxide in the treatment of hypertensive emergencies].
    Sterian C; Purea HH; Roşu D
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(3):243-50. PubMed ID: 41307
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of sodium and water excretion and of plasma renin activity (PRA) after administration of furosemide in patients with glomerulonephritis with various degrees of functional deficiency and arterial pressure levels].
    Cappelli G; Di Maio G; Lamperi S
    Boll Soc Ital Biol Sper; 1976 Dec; 52(23):1991-6. PubMed ID: 1027472
    [No Abstract]   [Full Text] [Related]  

  • 7. Antihypertensive agents in renal disease.
    White RP
    Am J Med; 1977 Apr; 62(4):539-41. PubMed ID: 851127
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of prazosin in management of hypertension in patients with chronic renal failure and in renal transplant recipients.
    Curtis JR; Bateman FJ
    Br Med J; 1975 Nov; 4(5994):432-4. PubMed ID: 811312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypotensive and renin-suppressing activities of propranolol in hypertensive patients.
    Leonetti G; Mayer G; Morganti A; Terzoli L; Zanchetti A; Bianchetti G; Di Salle E; Morselli PL; Chidsey CA
    Clin Sci Mol Med Suppl; 1975 Jun; 48(6):491-9. PubMed ID: 1056279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-dependent hypertension in children with reflux nephropathy.
    Siegler RL
    Urology; 1976 May; 7(5):474-8. PubMed ID: 1274003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose frusemide in the treatment of hypertension in chronic renal insufficiency and of terminal renal failure.
    Rastogi SP; Volans G; Elliott RW; Eccleston DW; Ashcroft R; Webster D; Kerr DN
    Postgrad Med J; 1971 Apr; 47():Suppl:45-53. PubMed ID: 5579771
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of essential hypertension with propranolol (author's transl)].
    Klumpp F; Braun B; Klaus D; Lemke R; Zehner J
    Dtsch Med Wochenschr; 1976 Oct; 101(41):1482-8. PubMed ID: 183943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alpha-methyldopa and renal function in arterial hypertension].
    Pessina AC; Hlede M; Pigato R; Palatini P; Dal Palù C
    Clin Ter; 1980 May; 93(3):287-94. PubMed ID: 7449342
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of antihypertensive drugs on dialysis-resistant hypertension, plasma renin and dopamine betahydroxylase activities, metabolic risk factors and calcium phosphate homeostasis: comparison of metoprolol, alphamethyldopa and clonidine in a cross-over trial.
    de Fremont JF; Coevoet B; Andrejak M; Makdassi R; Quichaud J; Lambrey G; Gueris J; Caillens C; Harichaux P; Alexandre JM; Fournier A
    Clin Nephrol; 1979 Nov; 12(5):198-205. PubMed ID: 509793
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal involvement in progressive systemic sclerosis: prolonged survival with aggressive antihypertensive management.
    Markenson JA; Sherman RL
    Arthritis Rheum; 1979 Oct; 22(10):1132-4. PubMed ID: 158363
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypertension of renal origin].
    Rorive G
    Rev Med Liege; 1973 Jul; 28(13):464-71. PubMed ID: 4732149
    [No Abstract]   [Full Text] [Related]  

  • 17. Salt, frusemide and renin in severe experimental renal hypertension.
    Fernandes M; Onesti G; Dykyj R; Fiorentini R; Gould AB; Kim KE; Swartz C
    Clin Sci Mol Med Suppl; 1976 Dec; 3():129s-132s. PubMed ID: 1071587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs used in the treatment of hypertension.
    Finnerty FA
    Mod Concepts Cardiovasc Dis; 1973 Jul; 42(7):33-6. PubMed ID: 4786758
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of large doses of furosemide in end-stage chronic renal failure.
    Vereerstraeten PJ; Dupuis F; Toussaint C
    Nephron; 1975; 14(5):333-8. PubMed ID: 1094314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood pressure in chronic renal failure. Effect of sodium intake and furosemide.
    Ulvila JM; Kennedy JA; Lamberg JD; Scribner BH
    JAMA; 1972 Apr; 220(2):233-8. PubMed ID: 5066855
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.